US Patent Issued to Novocure on Nov. 3 for "Increasing the efficacy of tumor treating fields (TTFields) by applying the TTFields at peak intensity less than half the time" (Israeli Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,217, issued on Nov. 3, was assigned to Novocure GmbH (Baar, Switzerland).

"Increasing the efficacy of tumor treating fields (TTFields) by applying the TTFields at peak intensity less than half the time" was invented by Moshe Giladi (Haifa, Israel), Eyal Dor-On (Haifa, Israel), Einav Zeevi (Haifa, Israel) and Rotem Engelman (Haifa, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "An alternating electric field may be applied to a target region in a living body or to cells in vitro. The alternating electric field is applied during a first interval of time that is at least 1 hour long. The first interval of time includes a plurality of (e.g., 10) no...